Relative Flow Reserve
pronounced response to an adenosine challenge, the pressure will drop more at the level of the stenosis than in the vessel in which the hyperemic response is blunted. Therefore, in patients with poor microvascular response, even angiographically severe stenosis cannot cause significant pressure gradients. On the other hand, in the case of a good microvascular response, even a mild stenosis can cause a pressure gradient, whereas the absolute stress MBF may remain above the level of ischemia.
Hyperemic MBF is a composite measurement of an entire single coronary vascular bed affected by an epicardial stenosis and microvascular resistance. Thus, MBF cannot separate effects of a specific lesion from those of microvascular dysfunction. In the case of poor microvascular function, MBF becomes abnormal even without obstructive epicardial disease. Consequently, disconcordance between FFR and hyperemic perfusion can frequently be observed because of differences in underlying physiological processes. 8 From quantitative MBF measurements, relative flow reserve (RFR), defined as the ratio of hyperemic MBF in a stenotic area to hyperemic MBF in a normally perfused area, can be calculated. 9 Small-scale studies have demonstrated good agreement between FFR and RFR. [9] [10] [11] Data on diagnostic performance of RFR for detection of CAD are, however, lacking. The aim of this study was to validate RFR against FFR.
Methods

Patient Population
Ninety-two patients with documented single-or 2-vessel disease based on invasive coronary angiography (ICA) and at least a single reference vessel without a diameter stenosis of >30% were included. These selection criteria were applied as RFR calculations requiring a normal vascular reference area as previously described by de Bruyne et al. 9 Both schematic illustration and rationale of RFR calculation are shown in Figure 1 . In the case of 2 diseased vessels within a patient, 1 vessel was randomly selected for the current analysis. The patients included in the current analysis were derived from a recently published larger cohort of subjects suspected of CAD, who were referred for ICA in conjunction with FFR measurements and underwent [ 15 O]H 2 O PET imaging before ICA. 7 Exclusion criteria were previous percutaneous coronary intervention, coronary artery bypass graft surgery, previous myocardial infarction, atrial fibrillation, second-or third-degree atrioventricular block, impaired renal function, symptomatic asthma, or pregnancy. Electrocardiography and echocardiography were used to confirm normal global left ventricular systolic function and absence of regional wall motion abnormalities in all patients. Vessels with an intermediate stenosis (30%-90%) without FFR interrogation were excluded from analysis because of the inability to determine the functional relevance of the lesion. This study was approved by the Ethics Committee of the VU University Medical Center.
PET Imaging
PET studies using [ 15 O]H 2 O were performed as described previously. 7 In short, patients were scanned on a PET/computed tomographic device according to a site-specific scanning protocol. All patients were informed to refrain from any caffeine or xanthine containing products for 24 hours before scanning. A dynamic emission scan was performed at rest followed by an identical scan during intravenous adenosine-induced hyperemia. Low-dose computed tomographic scans were used to correct for scatter and attenuation. 12 Parametric MBF images were generated and analyzed quantitatively using Cardiac VUer or Carimas. 13, 14 MBF was expressed in milliliter per minute per gram of perfusable tissue. MBF and CFR were calculated for each of the 3 vascular territories left anterior descending, circumflex, and right coronary artery according to standard segmentation procedures. 15 CFR was calculated as the ratio of hyperemic MBF to baseline MBF for each of the vascular territories.
Invasive Coronary Angiography
ICA imaging was obtained in ≥2 orthogonal directions for each coronary artery using intracoronary administration of 0.2 mL of nitroglycerin before contrast injection to induce epicardial coronary vasodilation. Intermediate coronary lesions (diameter stenosis, 30%-90%) were interrogated by FFR. The operator refrained from FFR measurements in (sub) total (90%-100%) lesions to minimize the risk of provoking pressure wire-related complications. For study purposes, 64 (53%) of the nonstenotic (ie, <30% diameter stenosis) Figure 1 . Schematic illustration displaying the rationale of relative flow reserve (RFR) and fractional flow reserve (FFR) as comparable physiological parameters to evaluate the functional significance of a coronary stenosis. FFR is the ratio of hyperemic flow in the vascular territory subtended by the affected artery (A) to hyperemic flow in the same region in the hypothetical case of a normal artery (A′), which corresponds to the ratio of mean arterial pressure distal and proximal (A″) of the stenosis during hyperemia. RFR is the ratio of hyperemic myocardial blood flow in the affected vascular territory (A) to flow in a normal reference This concept relies on 2 assumptions. First, hyperemic minimal microvascular resistance is homogenous throughout the myocardium independent of the presence of epicardial coronary lesions. Second, the normal reference vessel is free from atherosclerosis without hyperemic pressure decline of the conduit epicardial segment. The latter assumption, however, is debatable as a nonsignificant hyperemic pressure decline (and thus FFR) can frequently be observed in coronary arteries without apparent obstructive lesions. hMBF indicates hyperemic myocardial blood flow; LAD, left anterior descending; and RCA, right coronary artery.
RFR reference vessels were also interrogated by FFR. All patients exposed to additional FFR measurements provided written informed consent. FFR was measured using a 0.014-inch sensor-tipped guidewire, calibrated, and advanced into the coronary artery. The use of intracoronary (150 µg; n=54) or intravenous (140 μg•kg −1
•min −1 ; n=38) adenosine, to induce maximal coronary hyperemia during FFR interrogation, was left to the discretion of the operator. 7, 16 FFR was calculated as the ratio of the mean distal intracoronary pressure, measured by the pressure wire, to the mean arterial pressure measured using the coronary catheter. 17 A stenosis with ≥90% luminal diameter reduction or with an FFR of ≤0.80 was considered hemodynamically significant. 18 A coronary artery with <30% luminal narrowing was considered normal and served as a reference for PET calculations. 19, 20 The coronary tree was divided into a 16-segment coronary artery model modified from the American Heart Association. 15 Quantitative coronary angiography was performed on all coronary segments of >2.0 mm in diameter (Xcelera; Philips Healthcare, Best, The Netherlands).
Calculation of RFR
RFR was calculated as the ratio of hyperemic MBF of a stenotic myocardial area to hyperemic MBF of a nonstenotic reference vascular territory. Parametric hyperemic MBF polar maps were visually assessed to delineate defect areas, and quantitative MBF values of stenotic vessels were obtained for the ischemic segments only as opposed to entire vascular territories.
RFR = stenotic hyperemic MBF / reference hyperemic MBF
Statistical Analysis
Continuous variables are presented as mean values±SD, whereas categorical variables are expressed as actual numbers. Continuous variables of paired data were compared with the paired sample t test, whereas comparisons between groups were performed using the 2-independent sample t test, unless stated otherwise. Paired non-normal data were analyzed with the Wilcoxon signed-rank test where appropriate. Comparison of differences in myocardial perfusion, RFR, and FFR between groups with different CAD severities was performed using 1-way ANOVA and a post hoc Bonferroni for localizing the source of the difference. The association between FFR and RFR was evaluated using Spearman correlation analysis because both variables are non-normal data. Both receiver operator characteristic (ROC) curve analysis and Youden Index were used to define optimal cutoff values for hyperemic MBF. The areas under the curves of hyperemic MBF and RFR were compared with the method of DeLong et al. 21 The incremental value of RFR compared with hyperemic MBF alone was determined with the area under the ROC curve (AUC) analysis based on a combination of parameters in the logistic regression model and the net reclassification index. 22 Diagnostic performance of hyperemic MBF and RFR and RFR, in addition to hyperemic MBF, for the diagnosis of significant CAD was determined with sensitivity, specificity, negative predictive value, positive predictive value, and accuracy, including their related 95% confidence intervals, on a pervessel basis. No corrections were necessary for the site the data came from because a linear mixed model did not expose any significant effect of the site on the results. In addition, intraclass correlations confirmed no strong relationship between the data and the site the data came from. Based on ROC curve analysis of previously published data, 7 the sample size of this study was 87 to detect a 10% difference in AUC with an α of 0.05 and a power of 0.80 in a population with a prevalence of disease of 40%. Statistical analyses were performed using IBM SPSS software (IBM SPSS Statistics 20.0, Chicago, IL) or MedCalc software (MedCalc Software 12.5.0.0, Ostend, Belgium).
Results
Baseline patient characteristics are shown in Table 1 . Ninetytwo patients, from the VU University Medical Center (n=60), Turku University Hospital (n=28), and Uppsala University Hospital (n=4), who underwent both [ 15 
O]H 2 O PET imaging and
ICA/FFR were included for analysis. No cardiac events or procedural-related complications were documented between PET and ICA. A total of 92 coronary lesions were used for analysis of RFR. All intermediate stenotic vessels (30%-90% diameter stenosis) were interrogated by FFR (n=75; 82%); 17 (18%) vessels displayed a subtotal stenosis of ≥90% and were deemed hemodynamically significant. Thirty-eight (41%) lesions were graded hemodynamically significant determined by an FFR of ≤0.80 (n=21) or diameter stenosis of ≥90% (n=17). In addition, 43 (47%) reference vessels were also interrogated by FFR with an average value of 0.94±0.06. Table 2 lists the characteristics of the coronary arteries analyzed. 
Hemodynamic Conditions During PET
The hemodynamic conditions during rest and vasodilator PET are summarized in Table 3 . The heart rate and rate-pressure product increased from rest to stress imaging (both P<0.001).
There were no significant differences in the heart rate, blood pressure, or rate-pressure product for rest and stress imaging between patients with or without hemodynamically significant CAD. ; P<0.001; Table 5 ). Baseline MBF was not affected by hemodynamically significant CAD (Figure 2 ).
Myocardial Blood Flow
Coronary Flow Reserve
The mean CFR of stenotic vessels was significantly lower compared with the CFR of the reference vessels (2.76±1.25 versus 3.32±1.24; P<0.001, respectively). Within stenotic vessels, the CFR was lower for vessels with a hemodynamically significant lesion than that for vessels with an FFR of >0.80 (2.27±1.03 versus 3.10±1.29; P=0.001, respectively; Table 5 ).
Relative Flow Reserve
RFR was calculated for all stenotic vessels (n=92). FFR measurements were performed in stenotic vessels with intermediate lesions (diameter stenosis, 30%-90%; n=75). The average RFR was 0.83±0.22 for all vessels. The RFR for vessels with an intermediate stenosis was 0.88±0.19 and was not significantly different compared with the average FFR of these arteries (0.85±0.14; P=0.12; n=98). The mean difference between FFR and RFR was 0.04±0. 16 . RFR in relation to lesion severity and in comparison with FFR is shown in Table 4 . RFR was lower for vessels with a hemodynamically significant lesion Figure 2 ). The correlation between FFR and RFR, and its corresponding Bland-Altman plot, is given in Figure 3 .
Diagnostic Accuracy of Hyperemic MBF, CFR, and RFR
ROC analysis revealed an AUC of 0.76 for hyperemic MBF, 0.72 for CFR, and 0.82 for RFR (P=0.32 for RFR versus hyperemic MBF, P=0.08 for RFR versus CFR, and P=0.18 for hyperemic MBF versus CFR; Figure 4 ; Table 6 ). The optimal cutoff values for hyperemic MBF, CFR, and RFR were 2.35, 2.58, and 0.69 mL·min
, respectively. Sensitivity, specificity, negative predictive value, positive predictive value, and accuracy of hyperemic MBF, CFR, and RFR, and RFR in combination with hyperemic MBF for predicting abnormal FFR are shown in Table 7 . The agreement of RFR with FFR is shown in Figure 3 
Discussion
This study was conducted to evaluate the agreement between RFR and FFR and to determine the diagnostic accuracy of RFR in assessing significant CAD in patients with single-or 2-vessel CAD. Results indicate that RFR values were not significantly different compared with FFR values; however, the correlation between these parameters is only moderate. In addition, diagnostic accuracy of RFR for detecting functionally CAD was not evidently better than that of hyperemic MBF and CFR in the current analysis.
RFR versus FFR
For intermediate stenotic lesions, PET-derived RFR correlation with FFR was only moderate. These results are in contrast to previous RFR validation studies, which yielded a high agreement. 9, 11 The differences between these studies that used the same PET and FFR technology are likely because of patient selection. These earlier studies carefully identified patients with single CAD together with isolated discrete lesions in the absence of any atherosclerotic features of the reference vessels. In contrast, in this study, patients were selected from a consecutive cohort of patients who underwent PET and FFR and displayed single-or 2-vessel CAD. In each of these patients, a reference vessel was identified based on a stenosis diameter of <30%. Nevertheless, frequently diffuse atherosclerosis without a focal lesion was observed in these arteries, questioning whether they can be used as a reference. In fact, in the subgroup of patients in whom FFR was measured in the reference artery, an FFR of 0.94 was obtained, indicating a hyperemic pressure decline across the course of the artery even in the absence of apparent stenosis. Previously, this phenomenon has been documented by de Bruyne et al. 23 As opposed to FFR, RFR depends on the validity of a true normal reference area and the slight decrease in hyperemic MBF because diffuse atherosclerosis results in overestimation of RFR relative to FFR. This overestimation does not indicate a limited correlation because the correlation between 2 parameters can be high if a fixed offset is apparent. However, the correlation between FFR and RFR was limited, which indicates that in a consecutive, clinical patient population with single-or 2-vessel disease, RFR does not seem to robustly mimic invasive FFR. In addition, a relevant number of vessels with an FFR of >0.80 display abnormal hemodynamics because of microvascular dysfunction. 24 Identification of microvascular dysfunction, in addition to FFR, is essential to guide clinical management in a judicious manner. [25] [26] [27] Furthermore, impaired vasomotor function is a significant prognostic predictor, suggesting that myocardial perfusion is relevant despite the value of FFR. as the optimal cutoff value to detect hemodynamically significant CAD based on an FFR cutoff value of 0.80. The corresponding diagnostic accuracy was 84% on a per-vessel basis and 85% on a per-patient basis, which was in line with previous studies. In this study, using a selection of patients from the same data set, a lower diagnostic accuracy of hyperemic MBF on a per-vessel basis (74%) was obtained for the same cutoff value. This lower diagnostic accuracy is the result of selection bias, whereby the classification agreement between measurements will decrease when continuous values studied are close to an established cutoff value (FFR, 0.80), which is the case because of studying diseased vessels only in this study. Adding unaffected scans with homogeneous perfusion will provide low incidence of false-negative test results and would improve the specificity of hyperemic MBF and RFR. Hyperemic MBF and FFR display a physiological disconcordancy in ≈25% of cases. 7, 8, 34 This is because of the variability in coronary microvascular resistance, whereby for a given FFR (of an epicardial lesion), hyperemic MBF is blunted or preserved in the case of augmented or low microvascular resistance, respectively. 8 Noninvasive PET-derived FFR estimation by RFR has similar dependency to variations of coronary microvascular resistance and should therefore, on a theoretical basis, display a higher concordancy with FFR than hyperemic MBF. Yet, the diagnostic accuracy and C-statistic at ROC analysis of RFR (82% and 0.82, respectively) were not significantly higher compared with those of hyperemic MBF (74% and 0.76, respectively), when taking an FFR of 0.80 as a reference. As already alluded to, reference arteries sometimes display diffuse subclinical atherosclerosis, which hampers the accuracy of RFR by lack of normally perfused myocardium. In addition, RFR is a ratio, whereby fluctuations in each of the 2 parameters used will induce noise and larger variability when compared with single measurements alone. A similar phenomenon has previously been documented with the ratio of CFR, which yields a lower diagnostic accuracy to diagnose CAD, as confirmed in this study, compared with hyperemic MBF alone. 
28,29
Clinical Implication of RFR
This study aimed to evaluate whether the theoretical benefit of noninvasive assessment of FFR by means of PET-derived RFR would translate into a higher diagnostic accuracy than hyperemic MBF alone. The data trends toward a higher diagnostic value; however, no significant improvement was found compared with that of hyperemic MBF alone. This parameter is further limited by the fact that it can only be used in patients with single-or 2-vessel disease because a normal reference territory is required for its assessment. It can thus only be calculated in combination with anatomic imaging either by invasive or computed tomography-based coronary angiography. Because RFR did not add significant incremental value compared with hyperemic MBF, the application in clinical practice cannot be established yet. This is in line with the results obtained by Hajjiri et al, 36 who demonstrated that the relative uptake ratio of impaired perfusion in relation to a normal reference area using [ 13N ] NH 3 PET was inferior to hyperemic perfusion in diagnosing obstructive CAD.
Coronary Flow Reserve
Consistent with previously published data, CFR does not seem to level with absolute hyperemic MBF when it comes to diagnostic accuracy for predicting hemodynamically significant CAD as reflected by an FFR of ≤0.80 in this study. 7, 31, 33, 35 However, Johnson et al 8 showed an useful approach combining both hyperemic MBF and CFR to account for diffuse low perfusion because of risk factors or clinical circumstances, which is essential because of its prognostic value.
28,29
Cutoff Values
Cutoff values for hyperemic MBF and CFR in this study seem rather high compared with previously reported cutoff values. 37, 38 However, the lack of this uniformity may be attributed to study design and the use of different PET tracers. Because of individual kinetic properties, different PET tracers will provide various cutoff values.
Study Limitations
Intravenous administration of adenosine at a dose of 140 μg·kg·min −1 is considered to be the gold standard for FFR assessment. 6 This study used either intravenous or intracoronary adenosine to achieve hyperemia during FFR interrogation. Based on matching FFR-values between 140 μg•kg −1
•min −1 intravenous and 150 μg intracoronary as demonstrated by Casella et al, 16 150 μg adenosine was used as intracoronary dosage in this study.
Furthermore, with regard to grading of hemodynamically significant CAD, the assumption was made that a lesion of >90% diameter stenosis was hemodynamically significant, despite missing FFR measurements. Tonino et al 18 provided evidence that vessels with a stenosis of 90% to 99% were hemodynamically significant, graded by an FFR of ≤0.80, in 96% of the cases. Because of these lacking FFR values, correlation of FFR and RFR could only be provided for vessels with intermediate lesion severity.
Although site-specific differences in the scanning protocol and software packages exist in the current analysis, MBF extraction with Cardiac VUer and Carimas is similarly retrieved with highly comparable quantitative global and regional MBF values. 13, 39, 40 However, influence on the results cannot be entirely excluded because of the possible existence of significant offsets between different models, scan techniques, and reconstruction parameters. Furthermore, ratio measures, such as RFR, might be more robust to potential heterogeneity of these analyses in contrast to MBF. Consequently, caution must be maintained in interpreting the negativity of these results.
The current sample size was insufficient to detect a significant improvement of the AUC for RFR, although a trend toward a higher diagnostic accuracy for RFR was found. This could indicate that this study was hampered by limited statistic power. Given the preliminary nature of the findings, further investigation with a larger sample size is warranted.
This study investigated the diagnostic accuracy of RFR with FFR as a reference standard, whereas initially, FFR was validated against PET and other functional tests. [9] [10] [11] 17, 41 This circularity of literature should be taken into account when drawing conclusions to the results. However, RFR might compensate for the disconcordancy between FFR and hyperemic perfusion, which is frequently observed in patients with microvascular dysfunction, and data on the diagnostic performance of RFR are lacking.
Conclusions
Noninvasive estimation of FFR using quantitative perfusion PET by calculating RFR is feasible, yet only a trend toward a slight improvement of diagnostic accuracy compared with hyperemic MBF assessment was determined.
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